IN2012DN02073A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02073A IN2012DN02073A IN2073DEN2012A IN2012DN02073A IN 2012DN02073 A IN2012DN02073 A IN 2012DN02073A IN 2073DEN2012 A IN2073DEN2012 A IN 2073DEN2012A IN 2012DN02073 A IN2012DN02073 A IN 2012DN02073A
- Authority
- IN
- India
- Prior art keywords
- hcg
- including recombinant
- preparations including
- preparations
- recombinant hcg
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09252360 | 2009-10-05 | ||
| PCT/GB2010/001854 WO2011042688A1 (en) | 2009-10-05 | 2010-10-04 | Pharmaceutical preparation comprising recombinant hcg |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02073A true IN2012DN02073A (de) | 2015-08-21 |
Family
ID=41471027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2073DEN2012 IN2012DN02073A (de) | 2009-10-05 | 2010-10-04 |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US8975226B2 (de) |
| EP (2) | EP3611185A1 (de) |
| JP (6) | JP6176924B2 (de) |
| KR (7) | KR101804479B1 (de) |
| CN (1) | CN107050434B (de) |
| AR (2) | AR079876A1 (de) |
| AU (1) | AU2010304922B2 (de) |
| BR (1) | BR112012007990A2 (de) |
| CA (1) | CA2776790A1 (de) |
| DK (1) | DK2486051T3 (de) |
| ES (1) | ES2798258T3 (de) |
| HR (1) | HRP20200941T1 (de) |
| HU (1) | HUE050793T2 (de) |
| IL (3) | IL218548A (de) |
| IN (1) | IN2012DN02073A (de) |
| JO (1) | JOP20200039A1 (de) |
| LT (1) | LT2486051T (de) |
| MX (1) | MX2012003951A (de) |
| PL (1) | PL2486051T3 (de) |
| PT (1) | PT2486051T (de) |
| RS (1) | RS60413B1 (de) |
| RU (2) | RU2724528C2 (de) |
| SI (1) | SI2486051T1 (de) |
| TW (2) | TWI604850B (de) |
| WO (1) | WO2011042688A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
| TWI604850B (zh) * | 2009-10-05 | 2017-11-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| CA2831486A1 (en) | 2011-03-31 | 2012-10-04 | Ferring B.V. | Pharmaceutical preparation |
| WO2012168680A1 (en) * | 2011-06-06 | 2012-12-13 | Ferring B.V. | Pharmaceutical preparation comprising recombinant fsh |
| JO3092B1 (ar) * | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
| WO2013093760A2 (en) * | 2011-12-19 | 2013-06-27 | Grifols, S.A. | Compositions, methods, and kits for preparing sialylated recombinant proteins |
| EP4219705A1 (de) | 2012-12-10 | 2023-08-02 | Seikagaku Corporation | Verfahren zur herstellung eines rekombinanten faktors c, verfahren zur abschwächung der reaktionshemmung in endotoxintests und verfahren zur messung von endotoxin |
| EP3237608B1 (de) * | 2014-12-22 | 2019-10-09 | F. Hoffmann-La Roche AG | Cmp-abhängige sialidaseaktivität |
| EP3286209B1 (de) | 2015-04-24 | 2020-11-25 | Ferring BV | Verfahren zur herstellung von gonadotrophin |
| EP3628675A1 (de) | 2015-06-26 | 2020-04-01 | Ferring B.V. | Verfahren zur aufreinigung und/oder vireninaktivierung |
| TW201945024A (zh) | 2018-04-30 | 2019-12-01 | 荷蘭商菲林公司 | 用於經控制之卵巢刺激的組成物 |
| KR20220137651A (ko) * | 2020-02-05 | 2022-10-12 | 노파르티스 아게 | Il-15 이종이량체를 발현하는 cho 세포 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4840896A (en) * | 1983-11-02 | 1989-06-20 | Integrated Genetics, Inc. | Heteropolymeric protein |
| DK49987A (da) | 1987-01-30 | 1988-07-31 | Nordisk Gentofte | Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden |
| IT1206302B (it) | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
| DE69524456T2 (de) * | 1995-03-21 | 2002-08-01 | Applied Research Systems | Flüssige hcg-formulierungen |
| TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
| CN1302010C (zh) | 1997-06-25 | 2007-02-28 | 应用研究系统Ars股份公司 | 二硫键交联的糖蛋白激素类似物及其制备和应用 |
| US6500627B1 (en) | 1998-02-03 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Methods for predicting pregnancy outcome in a subject by HCG assay |
| WO2003050286A1 (en) * | 2001-10-29 | 2003-06-19 | Crucell Holland B.V. | Methods and means for producing proteins with predetermined post-translational modifications |
| US7695721B1 (en) | 1999-05-07 | 2010-04-13 | Merck Serono S.A. | Gonadotrophins in the treatment anovulatory women |
| EP1257564B1 (de) * | 2000-02-22 | 2008-08-27 | Laboratoires Serono SA | Verfahren zur reinigung vom recombinantem hcg mit spezifischer bioaktivität |
| MXPA04002256A (es) | 2001-09-12 | 2004-07-23 | Applied Research Systems | Uso de gonadotropina corionica humana (gch) en hiperestimulacion ovarica controlada. |
| MEP38608A (en) * | 2001-10-22 | 2011-02-10 | Merck Serono Sa | Gonadotrophins for folliculogenesis |
| BR0213402A (pt) * | 2001-10-29 | 2004-10-13 | Crucell Holland Bv | Métodos para identificar uma célula de mamìfero capaz de produzir uma molécula proteinácea, para selecionar uma célula de mamìfero capaz de produzir uma molécula proteinácea, para se obter uma célula de mamìfero a partir de uma população heterogênea de células, e para produzir uma molécula proteinácea, composição farmaceuticamente aceitável, eritropoietina recombinantemente produzida, usos de uma célula de mamìfero, da eritropoietina recombinantemente produzida, e de uma composição de moléculas semelhantes à eritropoietina, preparação farmacêutica, método para o tratamento preventivo e/ou terapêutico de um distúrbio, composição de moléculas semelhates à eritropoietina, métodos para produzir, em uma célula de mamìfero, moléculas proteináceas, para produzir uma fração enriquecida em uma molécula proteinácea, e para fracionar uma mistura que contém moléculas proteináceas, fração, e, usos de uma fração ou composição, e de eritropoietina recombinantemente produzìvel em uma célula de mamìfero |
| CN1374525A (zh) * | 2001-12-31 | 2002-10-16 | 陕西超英生物医学研究开发有限公司 | 一种抗体芯片、其制备技术及其检测方法 |
| EA200501548A1 (ru) | 2003-04-01 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | Ингибиторы фосфодиэстераз при бесплодии |
| EP1615945B1 (de) * | 2003-04-09 | 2011-09-28 | BioGeneriX AG | Glycopegylierungsverfahren und durch die verfahren hergestellte proteine/peptide |
| US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
| SI1654353T1 (sl) * | 2003-08-18 | 2013-09-30 | Glycotope Gmbh | Tumorski celični liniji NM-F9 (DSM ACC2606) in NM-D4 (DSM ACC2605), njihove uporabe |
| ATE476666T1 (de) * | 2004-02-04 | 2010-08-15 | Centre Nat Rech Scient | Verfahren zur identifizierung von glykoformspezifischen antikörpern |
| US8609370B2 (en) | 2004-02-13 | 2013-12-17 | Glycotope Gmbh | Highly active glycoproteins-process conditions and an efficient method for their production |
| US20100062973A1 (en) * | 2005-03-11 | 2010-03-11 | Fresenius Kabi Deutschland Gmbh | Production of bioactive glycoproteins from inactive starting material |
| US20070033927A1 (en) | 2005-08-15 | 2007-02-15 | Homby Michael J | Automotive diesel exhaust HC dosing valve |
| RU2309411C2 (ru) * | 2005-11-24 | 2007-10-27 | Ростовский НИИ акушерства и педиатрии МЗ РФ | Способ отбора пациенток с синдромом "пустых" фолликулов для проведения программы эко и пэ донорскими ооцитами |
| KR100809945B1 (ko) * | 2006-02-01 | 2008-03-05 | 대한민국 | 인체장내정상세균총 특이반응 ｄｎａ칩 및 이를 이용한인체장내정상세균총의 변화에 의한 인체 위해성의 평가방법 |
| US20080242607A1 (en) * | 2006-07-21 | 2008-10-02 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
| US20100075375A1 (en) * | 2006-10-03 | 2010-03-25 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates |
| TWI488640B (zh) * | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
| TWI604850B (zh) | 2009-10-05 | 2017-11-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| CA2831486A1 (en) * | 2011-03-31 | 2012-10-04 | Ferring B.V. | Pharmaceutical preparation |
| JO3092B1 (ar) * | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
-
2010
- 2010-09-27 TW TW104140348A patent/TWI604850B/zh active
- 2010-09-27 TW TW099132570A patent/TWI532495B/zh active
- 2010-10-04 KR KR1020127008827A patent/KR101804479B1/ko active IP Right Grant
- 2010-10-04 SI SI201032015T patent/SI2486051T1/sl unknown
- 2010-10-04 LT LTEP10763000.6T patent/LT2486051T/lt unknown
- 2010-10-04 KR KR1020217003233A patent/KR20210014767A/ko not_active IP Right Cessation
- 2010-10-04 MX MX2012003951A patent/MX2012003951A/es active IP Right Grant
- 2010-10-04 WO PCT/GB2010/001854 patent/WO2011042688A1/en active Application Filing
- 2010-10-04 CA CA2776790A patent/CA2776790A1/en active Pending
- 2010-10-04 DK DK10763000.6T patent/DK2486051T3/da active
- 2010-10-04 RU RU2016118236A patent/RU2724528C2/ru active
- 2010-10-04 KR KR1020217037028A patent/KR102489143B1/ko active IP Right Grant
- 2010-10-04 IN IN2073DEN2012 patent/IN2012DN02073A/en unknown
- 2010-10-04 HU HUE10763000A patent/HUE050793T2/hu unknown
- 2010-10-04 JP JP2012532657A patent/JP6176924B2/ja active Active
- 2010-10-04 BR BR112012007990A patent/BR112012007990A2/pt not_active Application Discontinuation
- 2010-10-04 AU AU2010304922A patent/AU2010304922B2/en active Active
- 2010-10-04 RU RU2012112907/10A patent/RU2588650C2/ru active
- 2010-10-04 KR KR1020177034392A patent/KR20170133531A/ko not_active IP Right Cessation
- 2010-10-04 EP EP19190372.3A patent/EP3611185A1/de active Pending
- 2010-10-04 ES ES10763000T patent/ES2798258T3/es active Active
- 2010-10-04 KR KR1020197007226A patent/KR101987982B1/ko active IP Right Grant
- 2010-10-04 US US13/500,274 patent/US8975226B2/en active Active
- 2010-10-04 EP EP10763000.6A patent/EP2486051B1/de active Active
- 2010-10-04 CN CN201610832288.8A patent/CN107050434B/zh active Active
- 2010-10-04 PL PL10763000T patent/PL2486051T3/pl unknown
- 2010-10-04 RS RS20200698A patent/RS60413B1/sr unknown
- 2010-10-04 KR KR1020197016021A patent/KR102213154B1/ko active IP Right Grant
- 2010-10-04 KR KR1020237001308A patent/KR20230012104A/ko not_active Application Discontinuation
- 2010-10-04 PT PT107630006T patent/PT2486051T/pt unknown
- 2010-10-05 AR ARP100103608A patent/AR079876A1/es not_active Application Discontinuation
-
2012
- 2012-03-08 IL IL218548A patent/IL218548A/en active IP Right Grant
-
2014
- 2014-05-21 US US14/283,904 patent/US9676835B2/en active Active
-
2015
- 2015-11-09 JP JP2015219480A patent/JP6310440B2/ja active Active
-
2017
- 2017-02-23 IL IL250733A patent/IL250733B/en active IP Right Grant
- 2017-05-03 US US15/586,010 patent/US10526390B2/en active Active
- 2017-10-24 JP JP2017205012A patent/JP6580104B2/ja active Active
-
2019
- 2019-06-20 IL IL267556A patent/IL267556A/en unknown
- 2019-08-27 JP JP2019154226A patent/JP7292153B2/ja active Active
- 2019-12-10 US US16/709,810 patent/US11292824B2/en active Active
-
2020
- 2020-02-17 JO JOP/2020/0039A patent/JOP20200039A1/ar unknown
- 2020-06-12 HR HRP20200941TT patent/HRP20200941T1/hr unknown
-
2021
- 2021-07-12 JP JP2021114833A patent/JP7196244B2/ja active Active
-
2022
- 2022-03-30 US US17/709,296 patent/US20220340634A1/en active Pending
- 2022-05-27 AR ARP220101408A patent/AR125991A2/es unknown
-
2023
- 2023-02-22 JP JP2023025781A patent/JP2023075144A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20200039A1 (ar) | مُستحضر صيدلي يشتمل على hcg مأشوب | |
| EP4302783A3 (de) | Modifizierte relaxinpolypeptide und deren verwendungen | |
| MX355457B (es) | Fsh recombinante que incluye alfa, 2-3- y alfa 2,6-sialilacion. | |
| IN2012DN06714A (de) | ||
| IN2011KN03851A (de) | ||
| UA103774C2 (uk) | Модифіковані поліпептиди бичачого гранулоцитарного колонієстимулювального фактора (g-csf) та їх застосування | |
| AU334234S (en) | Clamp for fence panels | |
| IN2012DN04748A (de) | ||
| IN2012DN04414A (de) | ||
| JO3755B1 (ar) | تركيبات تستوستيرون | |
| MX2012006980A (es) | Polipeptidos de somatotropina porcina modificados y sus usos. | |
| MX349301B (es) | Polipéptidos de somatotropina bovina modificados y sus usos. | |
| IN2011KN03928A (de) | ||
| MY168248A (en) | Next-instruction-type field | |
| JO3497B1 (ar) | مستحضر صيدلي يشتمل على hcg مأشوب | |
| GB2491544A (en) | Perpetum mobile | |
| IN2012DN04805A (de) | ||
| UA42262U (en) | 3-METHYL-7-β-HYDROXY-γ-(N-CHLOROPHENOXY)PROPYL-8-METHYLTHIOXANTINE EXHIBITING DIURETIC ACTION | |
| AU313101S (en) | Glass balustrading clamp - Frameless | |
| UA35660U (en) | Use of antihomotoxic preparations as cytoprotectors | |
| CL2009001949S1 (es) | Cajero automatico. | |
| AU333244S (en) | Control panel | |
| AU325379S (en) | Scarves | |
| UA34276U (ru) | 7-β-ГИДРОКСИЭТИЛ-3-МЕТИЛ-8-N-ПИРРОЛИДИНОКСАНТИН, КОТОРЫЙ ПРОЯВЛЯЕТ ДИУРЕТИЧЕСКОЕ ДЕЙСТВИЕ | |
| CL2009001548S1 (es) | Sillon. |